ABBV vs WST
By Alex · Tickerpine
AbbVie Inc. vs West Pharmaceutical Services, Inc., side by side — the numbers that matter, in plain English. No “winner” hype; you decide.
| Metric | ABBV | WST |
|---|---|---|
| Price | $253.35 | $350.85 |
| Market cap | $447.62B | $24.79B |
| P/E ratio | 123.6 | 47.0 |
| ROE | — | 19.13% |
| Profit margin | 5.79% | 16.85% |
| Revenue growth | 12.40% | 21.00% |
| Dividend yield | 2.73% | 0.25% |
| Beta | 0.31 | 1.18 |
Green = the more favorable figure for that metric (lower P/E, higher ROE, margin, growth and yield). Not a recommendation.
ABBV vs WST in plain English
- ABBV is the bigger company — about 18.1× the market cap of WST.
- WST is cheaper on earnings (P/E 47.0 vs 123.6).
- WST is growing revenue faster (21% vs 12%).
- ABBV has the higher dividend yield (2.73% vs 0.25%).
How would $1,000 have done in each?
ABBV return calculator
See what $1,000 in AbbVie Inc. would be worth today.
WST return calculator
See what $1,000 in West Pharmaceutical Services, Inc. would be worth today.
Figures from public market data, may be delayed. Comparison is informational only — not investment advice.